Savient Gets Nod For Ch. 11 Disclosure Statement
A Delaware bankruptcy judge on Monday approved Savient Pharmaceuticals Inc.'s Chapter 11 disclosure statement, allowing the drug developer to solicit votes for a liquidation plan that would see creditors divvy up...To view the full article, register now.
Already a subscriber? Click here to view full article